Financings in Brief: ChromaVision Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
ChromaVision Medical Systems: Firm's Aug. 13 initial public offering totals approximately 7.4 mil. shares, including the sale of 640,000 overallotment shares sold by certain shareholders, the firm states. ChromaVision netted $29.2 mil. from its sale of 6,020,000 new shares at $5 each ("The Gray Sheet" Aug. 25, p. 13); shareholders sold a total of 1,020,000 additional shares, including the overallotments, and Safeguard Scientifics, which held 37.4% of the automated microscope maker prior to the offering, sold some shares but also gained 320,000 additional new shares under terms of the offering. Safeguard currently holds about 20% of the company. About 17.1 mil. shares are currently outstanding. Underwriters were Robert W. Baird & Co. and Adams, Harkness & Hill...